期刊文献+

米卡芬净治疗儿童恶性血液病并侵袭性真菌感染30例 被引量:2

Malignant Hematological Disease Combined with Invasive Fungal Infection Treated with Micafungin in 30 Children
原文传递
导出
摘要 目的探讨米卡芬净(MCM)治疗儿童恶性血液病并侵袭性真菌感染(IFI)的疗效及安全性。方法选择2007年1月-2010年1月本院儿科血液/肿瘤病房诊治的恶性血液病并IFI患儿30例。包括ALL 12例,急性髓系白血病8例,复发难治性急性白血病5例,恶性淋巴瘤2例,急性再生障碍性贫血、慢性粒细胞性白血病同胞全相合造血干细胞移植、骨髓异常增生综合征各1例。应用MCM进行治疗,MCM剂量为3 mg.kg-1.d-1,1次.d-1,静脉输注,7 d为1个疗程,治疗1~4个疗程,同时动态监测1,3β--D葡-聚糖试验(G试验)、高分辨肺CT及各脏器功能指标。结果痊愈12例,显效6例,进步5例,无效7例,总有效率60%,病死率30%。本组患儿未发现肝肾功能、血液系统等不良反应。结论恶性血液病患儿是IFI的高发人群,诊断及治疗均存在难度,对IFI高危患儿进行G试验和高分辨肺CT动态监测,及早进行拟诊IFI是治疗成功的关键,MCM在恶性血液病并IFI患儿的治疗中显示了安全、有效的抗真菌作用。 Objective To explore the clinical effects and safety of micafungin(MCM) on malignant hematological disease combined with invasive fungal infection(IFI) in children.Methods Thirty IFI children with malignant hematological disease were selected for observation from Jan.2007 to Jan.2010 in the Department of Pediatric Hematology/Oncology.Among those children,12 cases were diagnosed as ALL,8 cases with acute myeloid leukemia,5 cases with relapsed or refractory acute leukemia,2 cases with lymphoma,1 case with acute aplastic anemia,1 chronic myelocytic leukemia child followed by transplantation with ploidentical sibling donor and 1 case with myelodysplastic syndrome.All the children received treatment of MCM for IFI.A dose of MCM 3 mg·kg-1·d-1 was administered for once-daily,7 days a cause of treatment,and the children received 1 to 4 coures individually.At meanwhile 1,3-β-D glucan assay(G test),high-resolution CT and the biochemical indexes for organs functions were kept on watch.Results In this group,12 cases were cured,6 cases turned better,5 cases improved clinically and 7 cases were invalid.The total effective rate was 60%,and the mortality was 30%.No side-effects were found in those children with MCM treatment.Conclusions Children with maligant hematological disease easily caught IFI.The diagnosis and treatment for it is quitely difficult while the mortality was quite high.The key points for successful treatment included early clinically presumed IFI with consecutive monitoring of G test as well as high-resolution CT,followed by effective antifungal drugs.MCM has reliable effects and it safe for IFI in children.
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2011年第3期171-173,共3页 Journal of Applied Clinical Pediatrics
关键词 恶性血液病 侵袭性真菌感染 米卡芬净 儿童 malignant hematological disease invasive fungal infection micafungin child
  • 相关文献

参考文献11

  • 1Grover ND. Echinocandins: A ray of hope in antifungal drug therapy [ J]. Indian J Pharmacol,2010,42 ( 1 ) :9 - 11.
  • 2Cross SA, Scott LJ. Micafungin: A review of its use in adults for the treatment of invasive and oesophageal candidiasis, and as prophylaxis against Candida infections [J]. Drugs ,2008,68 ( 15 ) :2225 - 2255.
  • 3黄晓军.血液病/恶性肿瘤患者侵袭性真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2005,44(7):554-556. 被引量:423
  • 4傅晨晓,周合冰,闫树旭.恶性血液病并发侵袭性真菌感染40例临床分析[J].现代预防医学,2010,37(9):1774-1775. 被引量:3
  • 5Tawara S,Ikeda F,Maki K,et aL In vitro activities of a new lipopeptide antifungal agent micafungin against a variety of clinically important fungi [ J ]. Antimicrob Agents Chemother, 2000,44 ( 1 ) : 57 - 62.
  • 6郝良纯.抗深部真菌感染药物——米卡芬净[J].实用临床医药杂志,2009,13(6):111-114. 被引量:14
  • 7Carter N J, Keating GM. Micafungin: A review of its use in the prophylaxis and treatment of invasive Candida infections in pediatric patients [J]. Paediatr Drugs,2009,11 (4) :271 -291.
  • 8Senn L, Owen Robinson J, Schmidt S, et al. 1,3 - β- D - gluean antigenemia for early diagnosis of invasive fungal infections in neutropenie patients with acute leukemia [J]. Clin Infect Dis, 2008,46 ( 6 ) : 878 - 885.
  • 9Obayashi T, Negishi K, Suzuki T, et al. Reappraisal of the serum ( 1→3 ) - beta - D - glucan assay for the diagnosis of invasive fungal infections - A study based on autopsy cases from 6 years [J]. Clin Infect Dis,2008,46 (12) : 1864 - 1870.
  • 10Ostrosky - Zeichner L, Alexander BD, Kett DH, et al. Muhicenter clinical evaluation of the ( 1→3 ) - beta - D - glucan assay as an aid to diagnosis of fungal infections in humans[J]. Clin Infect Dis,2005,41 (5) :654 -659.

二级参考文献30

共引文献436

同被引文献13

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部